Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 274,283 | 242,380 | 226,219 | 180,793 | 162,169 |
| Operating Income | -274,283 | -242,380 | -226,219 | -180,793 | -162,169 |
| Other Income | 27,776 | 29,550 | 59,646 | 40,075 | 25,089 |
| Pre-tax Income | -246,507 | -212,830 | -166,573 | -140,718 | -137,080 |
| Net Income Continuous | -246,507 | -212,830 | -166,573 | -140,718 | -137,080 |
| Net Income | $-246,507 | $-212,830 | $-166,573 | $-140,718 | $-137,080 |
| EPS Basic Total Ops | -1.81 | -1.56 | -1.22 | -1.04 | -1.02 |
| EPS Basic Continuous Ops | -1.81 | -1.56 | -1.22 | -1.04 | -1.02 |
| EPS Diluted Total Ops | -1.81 | -1.56 | -1.22 | -1.04 | -1.02 |
| EPS Diluted Continuous Ops | -1.81 | -1.56 | -1.22 | -1.04 | -1.02 |
| EPS Diluted Before Non-Recurring Items | -1.80 | -1.56 | -1.22 | -1.04 | -1.02 |
| EBITDA(a) | $-267,247 | $-239,447 | $-225,723 | $-180,832 | $-169,060 |